Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie B Spangler

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Cell Reports Methods|April 17, 2024
Directed-evolution approach to empower EGFR targeting for immunotherapyBunyarit Meksiriporn, Jamie B Spangler
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2020
Characterization of Immune Cell Subset Expansion in Response to Therapeutic Treatment in MiceJakub Tomala, Jamie B Spangler
Methods in Molecular Biology (Clifton, N.J.)|April 28, 2022
A Hybrid Adherent/Suspension Cell-Based Selection Strategy for Discovery of Antibodies Targeting Membrane ProteinsPatrick J Krohl, Jamie B Spangler
The Journal of Clinical Investigation|October 1, 2021
Insights into the anticancer mechanisms of interleukin-15 from engineered cytokine therapiesZachary J Bernstein, Jamie B Spangler
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2022
Joined at the hip: The role of light chain complementarity determining region 2 in antibody self-associationPaul R Sargunas, Jamie B Spangler
Nature Chemical Biology|July 2, 2021
Full speed AHEAD in antibody discoveryPaul R Sargunas, Jamie B Spangler
Advances in Experimental Medicine and Biology|October 20, 2019
Structural Basis for Signaling Through Shared Common γ Chain CytokinesHuilin Yang, Rakeeb Kureshi, Jamie B Spangler
Nature Cancer|March 30, 2023
Masking T cell engagers mitigates on-target off-tumor activityAliyah B Silver, Jeremy Wang, Jamie B Spangler
Journal of Immunology (Baltimore, Md. : 1950)|January 2, 2024
Engineering Anticytokine Antibodies for Immune ModulationJakub Tomala, Shanelle D Cao, Jamie B Spangler
Structure (London, England : 1993)|May 8, 2026
REAPing the benefits of comprehensive specificity profiling for therapeutic antibody developmentLuke M Tomasovic, Sofia Farhangnia, Jamie B Spangler
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Cell Reports Methods|April 17, 2024
Directed-evolution approach to empower EGFR targeting for immunotherapyBunyarit Meksiriporn, Jamie B Spangler
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2020
Characterization of Immune Cell Subset Expansion in Response to Therapeutic Treatment in MiceJakub Tomala, Jamie B Spangler
Methods in Molecular Biology (Clifton, N.J.)|April 28, 2022
A Hybrid Adherent/Suspension Cell-Based Selection Strategy for Discovery of Antibodies Targeting Membrane ProteinsPatrick J Krohl, Jamie B Spangler
The Journal of Clinical Investigation|October 1, 2021
Insights into the anticancer mechanisms of interleukin-15 from engineered cytokine therapiesZachary J Bernstein, Jamie B Spangler
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2022
Joined at the hip: The role of light chain complementarity determining region 2 in antibody self-associationPaul R Sargunas, Jamie B Spangler
Nature Chemical Biology|July 2, 2021
Full speed AHEAD in antibody discoveryPaul R Sargunas, Jamie B Spangler
Advances in Experimental Medicine and Biology|October 20, 2019
Structural Basis for Signaling Through Shared Common γ Chain CytokinesHuilin Yang, Rakeeb Kureshi, Jamie B Spangler
Nature Cancer|March 30, 2023
Masking T cell engagers mitigates on-target off-tumor activityAliyah B Silver, Jeremy Wang, Jamie B Spangler
Journal of Immunology (Baltimore, Md. : 1950)|January 2, 2024
Engineering Anticytokine Antibodies for Immune ModulationJakub Tomala, Shanelle D Cao, Jamie B Spangler
Structure (London, England : 1993)|May 8, 2026
REAPing the benefits of comprehensive specificity profiling for therapeutic antibody developmentLuke M Tomasovic, Sofia Farhangnia, Jamie B Spangler
Pageof 9